TY - JOUR
T1 - New 4-Functionalized Glutamate Analogues Are Selective Agonists at Metabotropic Glutamate Receptor Subtype 2 or Selective Agonists at Metabotropic Glutamate Receptor Group III
AU - Huynh, Tri H. V.
AU - Erichsen, Mette N.
AU - Tora, Amelie S.
AU - Goudet, Cyril
AU - Sagot, Emmanuelle
AU - Assaf, Zeinab
AU - Thomsen, Christian
AU - Brodbeck, Robb
AU - Stensbol, Tine B.
AU - Bjorn-Yoshimoto, Walden E.
AU - Nielsen, Birgitte
AU - Pin, Jean-Philippe
AU - Gefflaut, Thierry
AU - Bunch, Lennart
PY - 2016
Y1 - 2016
N2 - The metabotropic glutamate (Glu) receptors (mGluRs) play key roles in modulating excitatory neurotransmission in the brain. In all, eight subtypes have been identified and divided into three groups, group I (mGlu1,5), group II (mGlu2,3), and group III (mGlu4,6–8). In this article, we present a L-2,4-syn-substituted Glu analogue, 1d, which displays selective agonist activity at mGlu2 over the remaining mGluR subtypes. A modeling study and redesign of the core scaffold led to the stereoselective synthesis of four new conformationally restricted Glu analogues, 2a–d. Most interestingly, 2a retained a selective agonist activity profile at mGlu2 (EC50 in the micromolar range), whereas 2c/2d were both selective agonists at group III, subtypes mGlu4,6,8. In general, 2d was 20-fold more potent than 2c and potently activated mGlu4,6,8 in the low–mid nanomolar range.
AB - The metabotropic glutamate (Glu) receptors (mGluRs) play key roles in modulating excitatory neurotransmission in the brain. In all, eight subtypes have been identified and divided into three groups, group I (mGlu1,5), group II (mGlu2,3), and group III (mGlu4,6–8). In this article, we present a L-2,4-syn-substituted Glu analogue, 1d, which displays selective agonist activity at mGlu2 over the remaining mGluR subtypes. A modeling study and redesign of the core scaffold led to the stereoselective synthesis of four new conformationally restricted Glu analogues, 2a–d. Most interestingly, 2a retained a selective agonist activity profile at mGlu2 (EC50 in the micromolar range), whereas 2c/2d were both selective agonists at group III, subtypes mGlu4,6,8. In general, 2d was 20-fold more potent than 2c and potently activated mGlu4,6,8 in the low–mid nanomolar range.
U2 - 10.1021/acs.jmedchem.5b01333
DO - 10.1021/acs.jmedchem.5b01333
M3 - Journal article
C2 - 26814576
VL - 59
SP - 914
EP - 924
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
SN - 0022-2623
IS - 3
ER -